The acute efficacy and safety of dulaglutide in Japanese adults with type 2 Diabetes Mellitus

被引：0
|
作者：
Mizoguchi, Asako [1 ]
Imamine, Rui [1 ]
Kusama, Minoru [1 ]
Mase, Hajime [1 ]
Sato, Ai [1 ]
Minatoguchi, Makiko [1 ]
Watarai, Atsuko [2 ]
Kawamura, Takahiko [2 ]
Hotta, Nigishi [1 ]
Nakashima, Eitaro [1 ]
机构：
[1] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan
[2] Chubu Rosai Hosp, Res Ctr Promot Hlth & Employment Support, Nagoya, Aichi, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-58
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus
    Benavides, S
    Striet, J
    Germak, J
    Nahata, MC
    PHARMACOTHERAPY, 2005, 25 (06): : 803 - 809
  • [42] Efficacy and Safety of Retagliptin in Chinese Patients with Type 2 Diabetes Mellitus
    Pan, Changyu
    Lu, Juming
    Li, Xuefeng
    Yang, Gangyi
    Gao, Yongyi
    Guo, Lian
    Jiang, Hong
    Sun, Yadong
    DIABETES, 2015, 64 : A307 - A307
  • [43] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    O'Donoghue, Michelle L.
    Kato, Eri T.
    Mosenzon, Ofri
    Murphy, Sabina A.
    Cahn, Avivit
    Herrera, Marisol
    Tankova, Tsvetalina
    Smahelova, Alena
    Merlini, Piera
    Gause-Nilsson, Ingrid
    Langkilde, Anna Maria
    McGuire, Darren K.
    Wilding, John P. H.
    Leiter, Larry A.
    Bhatt, Deepak L.
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    DIABETOLOGIA, 2021, 64 (06) : 1226 - 1234
  • [44] Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus
    Forst, Thomas
    Pfuetzner, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (16) : 2281 - 2296
  • [45] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [46] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [47] Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients
    Kaku, Kohei
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (11) : 1313 - 1322
  • [48] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Hiroaki Iijima
    Takayuki Kifuji
    Nobuko Maruyama
    Nobuya Inagaki
    Advances in Therapy, 2015, 32 : 768 - 782
  • [49] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Iijima, Hiroaki
    Kifuji, Takayuki
    Maruyama, Nobuko
    Inagaki, Nobuya
    ADVANCES IN THERAPY, 2015, 32 (08) : 768 - 782
  • [50] THE EFFICACY OF SITAGLIPTIN ON INSULIN TREATMENT FOR JAPANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Matsuhashi, Y.
    Chikazawa, S.
    Matsui, J.
    Daimon, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S142 - S142
12345